7-Nov-2024 7:00 AM CST - Business Wire PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results and recent corporate highlights for the quarter ended September 30, 2024. We are pleased with the progress we have made across our pipeline and organization during the third quarter, as we continued to advance our lead
4-Nov-2024 7:00 AM CST - Business Wire PepGen to Participate in Upcoming Investor Conferences PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences: Guggenheim's Inaugural Healthcare Innovation Conference (Boston, MA) Monday, November 11, 2024 at 1:00 p.m. ET, Fireside Chat Stifel 2024 Healthcare Confere
7-Nov-2024 7:00 AM CST - Business Wire PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results and recent corporate highlights for the quarter ended September 30, 2024. We are pleased with the progress we have made across our pipeline and organization during the third quarter, as we continued to advance our lead
4-Nov-2024 7:00 AM CST - Business Wire PepGen to Participate in Upcoming Investor Conferences PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences: Guggenheim's Inaugural Healthcare Innovation Conference (Boston, MA) Monday, November 11, 2024 at 1:00 p.m. ET, Fireside Chat Stifel 2024 Healthcare Confere